Evidence map›Paper›PMID 34983445›Full record

ArticleBMC public health2022

Mongolia health situation: based on the Global Burden of Disease Study 2019.

Odgerel Chimed-Ochir, Vanya Delgermaa, Ken Takahashi, Oyuntsetseg Purev, Amarzaya Sarankhuu, Yoshihisa Fujino, Narantuya Bayarmagnai, Otgontuya Dugee, Ryenchindorj Erkhembayar, Battur Lkhagvaa and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. [Lip and oral cancers in East Asia from 1990 to 2035: trends of disease burden and future projections].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Odgerel Chimed-OchirDepartment of Public Health and Health Policy, Hiroshima University, Hiroshima, Japan.
Vanya DelgermaaWHO Representative Office in Mongolia, World Health Organization, Ulaanbaatar, Mongolia.
Ken TakahashiAsbestos Diseases Research Institute, Sydney, NSW, Australia.
Oyuntsetseg PurevPolicy Planning Department, Ministry of Health, Ulaanbaatar, Mongolia.
Amarzaya SarankhuuDepartment of Public Health, Ministry of Health, Ulaanbaatar, Mongolia.
Yoshihisa FujinoInstitute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan.
Narantuya BayarmagnaiCenter for Health Development in Mongolia, Ulaanbaatar, Mongolia.
Otgontuya DugeeNational Public Health Institute, Ministry of Health, Ulaanbaatar, Mongolia.
Ryenchindorj ErkhembayarDepartment of International Cyber Education, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Battur LkhagvaaNational Center for Communicable Diseases, Ulaanbaatar, Mongolia.
Chimedsuren OchirDepartment of International Cyber Education, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Tumenjavkhlan SosorburamPublic Health Department, For A Healthy Society, Ulaanbaatar, Mongolia.
Mohsen NaghaviInstitute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA. nagham@uw.edu.
Ministry of Health · MNMongolian National University of Medical Sciences · MNAsbestos Diseases Research Institute · AUHiroshima University · JPNational Center for Communicable Diseases · MNUniversity of Occupational and Environmental Health Japan · JPUniversity of Washington · US

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundOver the past few decades, economic, political, and social changes have directly and indirectly affected the health of the Mongolian population. To date, no comprehensive analysis has been conducted on the burden of diseases in this country. Thus, we aimed to describe the leading causes of death and disabling conditions and their trends between 1990 and 2019 in the Mongolian population.

methodsWe used the data from the Global Burden of Disease (GBD) 2019 study. In the current study, we examined life expectancy at birth, healthy life expectancy, the 20 leading causes of death, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted-life-years (DALYs), and the contribution of major risk factors to DALYs in Mongolia.

findingsThe life expectancy at birth in Mongolia has gradually increased since 1995 and reached 63.8 years for men and 72.7 for women in 2019. The highest increase in the age-standardised death rate between 1990 and 2019 occurred in alcohol use disorders (628.6%; 95% UI 10.0-1109.6) among men, and in liver cancer (129.1%; UI 65.3-222.4) among women. Ischaemic heart disease and stroke showed the highest rates of death, YLLs, and DALYs among both men and women. In 2019, the highest age-standardised rates of DALYs were attributable to high systolic blood pressure and dietary risks.

interpretationAlthough Mongolia saw substantial improvements across many communicable diseases, maternal and neonatal disorders, and under-5 mortality between 1990 and 2019, non-communicable diseases remained leading causes of mortality. The mortality from the most preventable causes such as injury, alcohol use, and dietary risks remain substantially high, suggesting that individual and social efforts are needed to tackle these diseases. Our analyses will support the development of policy priorities and action plans in multiple sectors to improve the overall health of the Mongolian population.

fundingBill & Melinda Gates Foundation.

Indexed as

AlcoholismGlobal Burden of DiseaseCause of DeathFemaleGlobal HealthHumansInfant, NewbornLife ExpectancyMaleMongoliaQuality-Adjusted Life YearsRisk Factors

Identifiers

PMID34983445
PMCPMC8729000
OpenAlexW4206728561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.